Cipla Q3 Results FY2023, PAT at Rs.801 crores
On 25th January 2023, Cipla announced its results for the third quarter of FY2023.
Key Highlights:
- Revenues from operations at Rs. 5810 crores
- EBITDA stood at Rs. 1408 crores
- The company reported PAT at Rs. 801 crores
Business Highlights:
- One-India business segment reported a robust double-digit traction in the core portfolio across therapies and business segments; 11% YoY ex-covid growth
- US business reported highest ever quarterly revenue of $195 Million and 30% YoY growth; Strong traction in the differentiated portfolio including market share expansion in key respiratory and peptide injectable products
- South Africa, Sub-Saharan Africa, And Global Access (SAGA) business’ supply challenges being addressed
- International Markets reported revenue impacted by currency volatility; 6% YoY ex-covid growth in INR terms
- API continued growth in emerging markets offsetting normalization in inventory levels for European customers
- R&D investments stand at Rs. 363 crores or 6.2 % of sales; Higher 39% YoY driven by ongoing clinical trials on a respiratory asset and other developmental efforts continuing including biosimilars
Commenting on the results, Umang Vohra, MD and Global CEO, Cipla Ltd, said: “Our Q3FY23 performance reflects sustained momentum in core One-India and US businesses driving our overall revenue growth of 6% reported and 11% on an excovid basis. Our One India franchise delivered strong performance across therapies and segments with double-digit market-beating growth in prescription on a covid adjusted base. We achieved the highest-ever quarterly revenue for the North American region of $195 Mn driven by the contribution of differentiated products and market share expansion in flagship respiratory and peptide franchises. Our reported operating profitability of 24.2% reflects our focused efforts on navigating external headwinds and continued higher R&D spending stemming from ongoing respiratory trials and initiation of biosimilar programs.”
Share Market Today
Indices Name | Price | Price Change (% change) |
---|---|---|
S&P ASX 200 | 7638.10 | 24.4 (0.32%) |
CAC 40 | 8023.26 | 0 (0%) |
DAX | 17837.40 | 67.38 (0.38%) |
Dow Jones | 37775.38 | 22.07 (0.06%) |
FTSE 100 | 7882.83 | 22.74 (0.29%) |
Hang Seng | 16385.87 | 0 (0%) |
US Tech Composite | 15606.50 | -81.87 (-0.52%) |
Nikkei 225 | 37574.56 | -505.14 (-1.33%) |
S&P 500 | 5011.12 | -11.09 (-0.22%) |
Gift Nifty | 22015.00 | -97 (-0.44%) |
Shanghai Composite | 3074.22 | 0 (0%) |
Taiwan Weighted | 20301.20 | 87.87 (0.43%) |
US 30 | 37723.60 | -5 (-0.01%) |
Start Investing in 5 mins*
Rs. 20 Flat Per Order | 0% Brokerage